Pfizer Shot Protected Fewer Than 2 In 10 Kids, NY Health Dept Admits (Pfizer Shot Only 12% Effective…)

Pfizer Shot Protected Fewer Than 2 In 10 Kids, NY Health Dept Admits.

Pfizer and BioNTech’s COVID-19 vaccine protected just 12 percent of children aged five to 11 against COVID-19 infection, according to a study conducted by the New York State Department of Health.

The study focused on how the vaccine protected children against the Omicron variant of the virus during the strain’s December 13th through January 24th surge. The 12 percent figure – which translates to the vaccine conferring roughly one in 10 children with protection against the variant – comes amidst several states and schools rolling out vaccine mandates for kids.

“During Omicron variant predominance, vaccine effectiveness against infection declined rapidly for New York State children 5- 11 years, with low protection by one month following full-vaccination. Among children 12-17, protection declined substantially, albeit more slowly than observed among younger children,” explained the study, which is still awaiting peer review.

“From December 13th, 2021 to January 30th, 2022, among 852,384 fully-vaccinated children 12 to 17 years and 365,502 children 5 to 11 years, vaccine effectiveness against cases declined from 66 percent to 51 percent for those 12 to 17 years and from 68 percent to 12 percent for those 5 to 11 years,” the paper, which used data from hospitals across the state, continued.

From January 24th to January 30th, vaccine effectiveness for 11 year olds dipped down to just 11 percent.

UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-03619
Issuer: PFIZER INC
Exchange: NEW YORK STOCK EXCHANGE LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 235 East 42nd Street
New York NEW YORK 10017
Telephone number: (212) 733-2323
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
0.250% Notes due 2022
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2022-03-07 By Lauren Frawley Analyst, Market Watch and Proxy Compliance
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.